Literature DB >> 32911281

Incidence and prevalence of giant cell arteritis and polymyalgia rheumatica: A systematic literature review.

Ankita Sharma1, Aladdin J Mohammad2, Carl Turesson3.   

Abstract

BACKGROUND: Giant cell arteritis (GCA; sometimes referred to as temporal arteritis) and polymyalgia rheumatica (PMR) are common and interrelated inflammatory conditions that almost exclusively affect adults older than 50 years. There is a need for updated information on the epidemiology of these diseases.
OBJECTIVE: This systematic literature review (SLR) aims to summarize current evidence regarding the global incidence and prevalence of GCA and PMR.
METHODOLOGY: A systematic search of PubMed and Google Scholar databases from their inception dates to July 30, 2019 for relevant publications was performed. Studies that reported incidence and/or prevalence estimates for GCA and/or PMR were identified. When there were multiple studies of the same population, the most recent estimates were used. Details on source populations and case validation were systematically reviewed. Results were tabulated per region in the world.
RESULTS: Screening by 2 authors resulted in 2643 abstracts, of which 77 articles met the inclusion criteria. There were more studies on GCA compared to PMR, and more on incidence than on prevalence. Wide variations were found in study design and populations studied. Studies that included a thorough case validation tended to give lower estimates, in particular for PMR. The highest incidence per 100 000 aged ≥50 years of GCA was observed in studies from Scandinavia and the UK (14.6 to 43.6), and in Minnesota, USA (19.8 per 100 000). Corresponding estimates for Southern Europe were lower (1.1 to 11.1). Limited evidence indicates that GCA and PMR is less common in non-Caucasian populations. Prevalence estimates for PMR were ≥ 3 times higher than that of GCA in Caucasians.
CONCLUSION: This SLR provides up to date estimates of the occurrence of GCA and PMR in different populations around the world. The incidence of GCA is higher in populations of Northern European ancestry. Data on the epidemiology of PMR are more limited, with greater variation in incidence and prevalence estimates.
Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2020        PMID: 32911281     DOI: 10.1016/j.semarthrit.2020.07.005

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  16 in total

Review 1.  Polymyalgia rheumatica and polymyalgia-like syndromes as adverse events following COVID-19 vaccines: working notes from a narrative review of published literature.

Authors:  Ciro Manzo; Alberto Castagna; Marco Isetta
Journal:  Reumatologia       Date:  2022-05-18

Review 2.  Novel PET Imaging of Inflammatory Targets and Cells for the Diagnosis and Monitoring of Giant Cell Arteritis and Polymyalgia Rheumatica.

Authors:  Kornelis S M van der Geest; Maria Sandovici; Pieter H Nienhuis; Riemer H J A Slart; Peter Heeringa; Elisabeth Brouwer; William F Jiemy
Journal:  Front Med (Lausanne)       Date:  2022-06-06

Review 3.  2-deoxy-2[18F]fluoro-D-glucose positron emission tomography-computed tomography in rheumatological diseases.

Authors:  Manil Subesinghe; Shaheel Bhuva; Nikita Arumalla; Andrew Cope; David D'Cruz; Sujith Subesinghe
Journal:  Rheumatology (Oxford)       Date:  2022-05-05       Impact factor: 7.046

Review 4.  Large-vessel vasculitis.

Authors:  Dan Pugh; Maira Karabayas; Neil Basu; Maria C Cid; Ruchika Goel; Carl S Goodyear; Peter C Grayson; Stephen P McAdoo; Justin C Mason; Catherine Owen; Cornelia M Weyand; Taryn Youngstein; Neeraj Dhaun
Journal:  Nat Rev Dis Primers       Date:  2022-01-06       Impact factor: 65.038

5.  New-onset versus relapsing giant cell arteritis treated with tocilizumab: 3-year results from a randomized controlled trial and extension.

Authors:  John H Stone; Helen Spotswood; Sebastian H Unizony; Martin Aringer; Daniel Blockmans; Elisabeth Brouwer; Maria C Cid; Bhaskar Dasgupta; Juergen Rech; Carlo Salvarani; Robert Spiera; Min Bao
Journal:  Rheumatology (Oxford)       Date:  2022-07-06       Impact factor: 7.046

Review 6.  Notch Signaling Regulation in Autoinflammatory Diseases.

Authors:  Rossella Gratton; Paola Maura Tricarico; Adamo Pio d'Adamo; Anna Monica Bianco; Ronald Moura; Almerinda Agrelli; Lucas Brandão; Luisa Zupin; Sergio Crovella
Journal:  Int J Mol Sci       Date:  2020-11-23       Impact factor: 5.923

7.  Reference programme: diagnosis and treatment of headache disorders and facial pain. Danish Headache Society, 3rd edition, 2020.

Authors:  Henrik W Schytz; Faisal M Amin; Rigmor H Jensen; Louise Carlsen; Stine Maarbjerg; Nunu Lund; Karen Aegidius; Lise L Thomsen; Flemming W Bach; Dagmar Beier; Hanne Johansen; Jakob M Hansen; Helge Kasch; Signe B Munksgaard; Lars Poulsen; Per Schmidt Sørensen; Peter T Schmidt-Hansen; Vlasta V Cvetkovic; Messoud Ashina; Lars Bendtsen
Journal:  J Headache Pain       Date:  2021-04-08       Impact factor: 7.277

8.  Epidemiology of biopsy-confirmed giant cell arteritis in southern Sweden-an update on incidence and first prevalence estimate.

Authors:  Pavlos Stamatis; Aleksandra Turkiewicz; Martin Englund; Carl Turesson; Aladdin J Mohammad
Journal:  Rheumatology (Oxford)       Date:  2021-12-24       Impact factor: 7.580

9.  Evaluation of revised classification criteria for giant cell arteritis and its clinical phenotypes.

Authors:  Frans Wiberg; Nazanin Naderi; Aladdin J Mohammad; Carl Turesson
Journal:  Rheumatology (Oxford)       Date:  2021-12-24       Impact factor: 7.580

10.  Patient perceptions of health-related quality of life in giant cell arteritis: international development of a disease-specific patient-reported outcome measure.

Authors:  Joanna C Robson; Celia Almeida; Jill Dawson; Alison Bromhead; Emma Dures; Catherine Guly; Elizabeth Hoon; Sarah Mackie; Mwidimi Ndosi; John Pauling; Catherine Hill
Journal:  Rheumatology (Oxford)       Date:  2021-10-02       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.